Maravai LifeSciences (NASDAQ:MRVI) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Maravai LifeSciences beat estimated earnings by 18.42%, reporting an EPS of $0.45 versus an estimate of $0.38.
Revenue was up $130.09 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 3.49% increase in the share price the next day.
Here's a look at Maravai LifeSciences's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | 0.35 | 0.31 | 0.20 | 0.11 |
EPS Actual | 0.44 | 0.44 | 0.26 | 0.13 |
Revenue Estimate | 201.50M | 192.29M | 138.49M | 89.02M |
Revenue Actual | 204.81M | 217.78M | 148.21M | 98.35M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.